The evolution of mendelian randomization for investigating drug effects
Public Library of Science
MetadataShow full item record
Gill, D., & Burgess, S. (2022). The evolution of mendelian randomization for investigating drug effects. [Other]. https://doi.org/10.1371/journal.pmed.1003898
Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.
Perspective, Biology and life sciences, Medicine and health sciences
External DOI: https://doi.org/10.1371/journal.pmed.1003898
This record's DOI: https://doi.org/10.17863/CAM.81024